CI Stock Overview
Cigna Corporation provides insurance and related products and services in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$236.25|
|52 Week High||US$272.81|
|52 Week Low||US$191.74|
|1 Month Change||6.26%|
|3 Month Change||9.17%|
|1 Year Change||5.74%|
|3 Year Change||20.36%|
|5 Year Change||60.92%|
|Change since IPO||3,429.05%|
Recent News & Updates
At US$231, Is It Time To Put Cigna Corporation (NYSE:CI) On Your Watch List?
Cigna Corporation ( NYSE:CI ) led the NYSE gainers with a relatively large price hike in the past couple of weeks. With...
Cigna: When Quality And Value Meet
Cigna’s third quarter results continue to show strong performance. Management reiterated their long-term goal of achieving 10% to 13% bottom line growth. Selling out of the money cash-secured puts will allow you to essentially have your cake, and eat it too. I rate Cigna a buy below $245.
Cigna's Value Keeps On Growing
Cigna has traded sideways since the Aetna acquisition in late 2018, but it has increased its financial strength substantially since then. Among the benefits flowing to shareholders since the acquisition that are not reflected in a higher stock price are a big dividend increase that may lead to more. Many stocks such as Cigna are out of favor with the market right now, but that may spell opportunity for you if you are a patient income investor.
|CI||US Healthcare||US Market|
Return vs Industry: CI underperformed the US Healthcare industry which returned 12.8% over the past year.
Return vs Market: CI matched the US Market which returned 6.6% over the past year.
|CI Average Weekly Movement||3.4%|
|Healthcare Industry Average Movement||7.9%|
|Market Average Movement||6.7%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: CI is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: CI's weekly volatility (3%) has been stable over the past year.
About the Company
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company’s U.S.
Cigna Fundamentals Summary
|CI fundamental statistics|
Is CI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CI income statement (TTM)|
|Cost of Revenue||US$147.03b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Feb 03, 2022
|Earnings per share (EPS)||25.30|
|Net Profit Margin||4.92%|
How did CI perform over the long term?See historical performance and comparison
1.7%Current Dividend Yield
Is Cigna undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CI ($236.25) is trading below our estimate of fair value ($416.91)
Significantly Below Fair Value: CI is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CI is good value based on its PE Ratio (9.3x) compared to the US Healthcare industry average (20.3x).
PE vs Market: CI is good value based on its PE Ratio (9.3x) compared to the US market (16.7x).
Price to Earnings Growth Ratio
PEG Ratio: CI is poor value based on its PEG Ratio (2.1x)
Price to Book Ratio
PB vs Industry: CI is good value based on its PB Ratio (1.7x) compared to the US Healthcare industry average (2.6x).
How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CI's forecast earnings growth (4.3% per year) is above the savings rate (2%).
Earnings vs Market: CI's earnings (4.3% per year) are forecast to grow slower than the US market (13.1% per year).
High Growth Earnings: CI's earnings are forecast to grow, but not significantly.
Revenue vs Market: CI's revenue (5.4% per year) is forecast to grow slower than the US market (9.2% per year).
High Growth Revenue: CI's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CI's Return on Equity is forecast to be low in 3 years time (14.6%).
How has Cigna performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CI has a large one-off gain of $3.8B impacting its September 30 2021 financial results.
Growing Profit Margin: CI's current net profit margins (4.9%) are higher than last year (3.4%).
Past Earnings Growth Analysis
Earnings Trend: CI's earnings have grown significantly by 33.5% per year over the past 5 years.
Accelerating Growth: CI's earnings growth over the past year (58.2%) exceeds its 5-year average (33.5% per year).
Earnings vs Industry: CI earnings growth over the past year (58.2%) exceeded the Healthcare industry 32.5%.
Return on Equity
High ROE: CI's Return on Equity (17.7%) is considered low.
How is Cigna's financial position?
Financial Position Analysis
Short Term Liabilities: CI's short term assets ($25.4B) do not cover its short term liabilities ($36.3B).
Long Term Liabilities: CI's short term assets ($25.4B) do not cover its long term liabilities ($70.4B).
Debt to Equity History and Analysis
Debt Level: CI's net debt to equity ratio (62%) is considered high.
Reducing Debt: CI's debt to equity ratio has increased from 36% to 72.2% over the past 5 years.
Debt Coverage: CI's debt is well covered by operating cash flow (21%).
Interest Coverage: CI's interest payments on its debt are well covered by EBIT (6.9x coverage).
What is Cigna current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CI's dividend (1.69%) is higher than the bottom 25% of dividend payers in the US market (1.36%).
High Dividend: CI's dividend (1.69%) is low compared to the top 25% of dividend payers in the US market (3.55%).
Stability and Growth of Payments
Stable Dividend: CI's dividends per share have been stable in the past 10 years.
Growing Dividend: CI's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (12.4%), CI's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CI's dividends in 3 years are forecast to be well covered by earnings (19% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Cordani (56 yo)
Mr. David Michael Cordani serves as Chair of the Board at Cigna Corporation since January 01, 2022. He has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and Ju...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD19.93M) is above average for companies of similar size in the US market ($USD11.42M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
Experienced Management: CI's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Experienced Board: CI's board of directors are considered experienced (3.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cigna Corporation's employee growth, exchange listings and data sources
- Name: Cigna Corporation
- Ticker: CI
- Exchange: NYSE
- Founded: 1981
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$78.300b
- Shares outstanding: 331.43m
- Website: https://www.cigna.com
Number of Employees
- Cigna Corporation
- Wilde Building
- 900 Cottage Grove Road
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/21 23:35|
|End of Day Share Price||2022/01/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.